XML 22 R12.htm IDEA: XBRL DOCUMENT
v3.22.2

EQUITY INVESTMENTS | 9 Months Ended
--- | ---
Jul. 02, 2022
Equity Method Investments [Abstract] |
EQUITY INVESTMENTS | 5. EQUITY INVESTMENTS Equity investments consisted of the following as of July 2, 2022 and October 2, 2021:
| As of
(in thousands) | July 2, 2022 |  | October 2, 2021
Non-marketable equity securities | $ | 5,397 |  |  | $ | 6,388 |
Total equity investments | $ | 5,397 |  |  | $ | 6,388 |
During the three and nine months ended July 2, 2022, the Company recorded an impairment of $1.3 million on a non-marketable equity security without a readily determinable fair value. The entire amount of the investment in the non-marketable equity security was impaired due to a significant deterioration in the earnings performance of the equity investee. The impairment amount is recorded within “Selling, general and administrative expense” in the Consolidated Condensed Statement of Operations.

X
- Definition Equity Method Investments [Abstract] + References No definition available. + Details
Name: | klic_EquityMethodInvestmentsAbstract
Namespace Prefix: | klic_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -URI http://asc.fasb.org/topic&trid=2196965 + Details
Name: | us-gaap_EquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration